ClinicalTrials.Veeva

Menu

Iron Absorption From GDS Capsules II

F

Federal Institute of Technology (ETH) Zurich

Status

Completed

Conditions

Iron Deficiency

Treatments

Dietary Supplement: GDS capsule with meal
Dietary Supplement: Ferrous sulfate with meal

Study type

Interventional

Funder types

Other

Identifiers

NCT01985386
EK 2013-N-05-2

Details and patient eligibility

About

Slow release iron capsules containing ferrous sulfate have been designed based on the gastric delivery system. Iron absorption from those capsules administered with and without meals will be measured using stable iron isotopes.

Enrollment

8 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • female,
  • age 18-50 years,
  • max. body weight 65 kg,
  • serum ferritin < 30 µg/l

Exclusion criteria

  • pregnancy,
  • lactation,
  • regular intake of medication,
  • blood donation or significant blood losses over the past 4 months

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

8 participants in 2 patient groups

GDS (gastric delivery system), meal
Experimental group
Description:
GDS capsule with meal
Treatment:
Dietary Supplement: GDS capsule with meal
Ferrous sulfate, meal
Active Comparator group
Description:
Ferrous sulfate with meal
Treatment:
Dietary Supplement: Ferrous sulfate with meal

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems